Motohiko Oshima

2.3k total citations
50 papers, 1.5k citations indexed

About

Motohiko Oshima is a scholar working on Molecular Biology, Hematology and Genetics. According to data from OpenAlex, Motohiko Oshima has authored 50 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Molecular Biology, 29 papers in Hematology and 8 papers in Genetics. Recurrent topics in Motohiko Oshima's work include Acute Myeloid Leukemia Research (22 papers), Epigenetics and DNA Methylation (19 papers) and Hematopoietic Stem Cell Transplantation (7 papers). Motohiko Oshima is often cited by papers focused on Acute Myeloid Leukemia Research (22 papers), Epigenetics and DNA Methylation (19 papers) and Hematopoietic Stem Cell Transplantation (7 papers). Motohiko Oshima collaborates with scholars based in Japan, United States and China. Motohiko Oshima's co-authors include Atsushi Iwama, Goro Sashida, Atsunori Saraya, Makiko Mochizuki‐Kashio, Changshan Wang, Haruhiko Koseki, Kazumasa Aoyama, Shuhei Koide, Yaeko Nakajima‐Takagi and Satoru Miyagi and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Circulation and Journal of Clinical Investigation.

In The Last Decade

Motohiko Oshima

49 papers receiving 1.5k citations

Peers

Countries citing papers authored by Motohiko Oshima

Since Specialization

Citations

This map shows the geographic impact of Motohiko Oshima's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Motohiko Oshima with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Motohiko Oshima more than expected).

Fields of papers citing papers by Motohiko Oshima

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Motohiko Oshima. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Motohiko Oshima. The network helps show where Motohiko Oshima may publish in the future.

Co-authorship network of co-authors of Motohiko Oshima

This figure shows the co-authorship network connecting the top 25 collaborators of Motohiko Oshima. A scholar is included among the top collaborators of Motohiko Oshima based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Motohiko Oshima. Motohiko Oshima is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	iPSC-derived megakaryocytes and platelets accelerate wound healing and angiogenesis 2024 ·Stem Cell Research & Therapy ·(unknown), Naoya Takayama, (unknown), (unknown), Motohiko Oshima, (unknown), Bahityar Rahmutulla, (unknown), (unknown), Yoshitaka Kubota, Shinsuke Akita, (unknown), Atsushi Kaneda, Atsushi Iwama, Koji Eto, Nobuyuki Mitsukawa	3
2	Noncanonical EZH2 drives retinoic acid resistance of variant acute promyelocytic leukemias 2022 ·Blood ·(unknown), Nadine Platet, (unknown), (unknown), (unknown), Shuhei Koide, Yaeko Nakajima‐Takagi, (unknown), Nadine Carbuccia, (unknown), (unknown), Motohiko Oshima, Daniel Birnbaum, Atsushi Iwama, Estelle Duprez	11
3	Clonal hematopoiesis with JAK2V617F promotes pulmonary hypertension with ALK1 upregulation in lung neutrophils 2021 ·Nature Communications ·Yusuke Kimishima, Tomofumi Misaka, Tetsuro Yokokawa, (unknown), Koki Ueda, Koichi Sugimoto, (unknown), Kazuhiko Nakazato, Takafumi Ishida, Motohiko Oshima, Shuhei Koide, Kotaro Shide, Kazuya Shimoda, Atsushi Iwama, Kazuhiko Ikeda, Yasuchika Takeishi	36
4	Insufficiency of non-canonical PRC1 synergizes with JAK2V617F in the development of myelofibrosis 2021 ·Leukemia ·(unknown), Yaeko Nakajima‐Takagi, Motohiko Oshima, Shuhei Koide, Kazumasa Aoyama, Atsunori Saraya, Hironori Harada, Bahityar Rahmutulla, Atsushi Kaneda, Kiyoshi Yamaguchi, Yoichi Furukawa, Haruhiko Koseki, Kazuya Shimoda, Tomoaki Tanaka, Goro Sashida, Atsushi Iwama	3
5	Overexpression of RUNX3 Represses RUNX1 to Drive Transformation of Myelodysplastic Syndrome 2020 ·Cancer Research ·Takako Yokomizo‐Nakano, Sho Kubota, Jie Bai, (unknown), (unknown), (unknown), Seiichiro Katagiri, (unknown), Akinori Kanai, (unknown), Motohiko Oshima, Yuka Harada, Kazuma Ohyashiki, Atsushi Iwama, Hironori Harada, Motomi Osato, Goro Sashida	14
6	Novel myocardial markers GADD45G and NDUFS5 identified by RNA-sequencing predicts left ventricular reverse remodeling in advanced non-ischemic heart failure: a retrospective cohort study 2020 ·BMC Cardiovascular Disorders ·(unknown), Sho Okada, (unknown), Motohiko Oshima, Atsushi Iwama, Goro Matsumiya, Yoshio Kobayashi	9
7	KDM2B in polycomb repressive complex 1.1 functions as a tumor suppressor in the initiation of T-cell leukemogenesis 2019 ·Blood Advances ·Yusuke Isshiki, Yaeko Nakajima‐Takagi, Motohiko Oshima, Kazumasa Aoyama, (unknown), Shuhei Kurosawa, Atsunori Saraya, Takashi Kondo, Emiko Sakaida, Chiaki Nakaseko, Koutaro Yokote, Haruhiko Koseki, Atsushi Iwama	20
8	Deregulated Polycomb functions in myeloproliferative neoplasms 2019 ·International Journal of Hematology ·Goro Sashida, Motohiko Oshima, Atsushi Iwama	9
9	Ezh2 loss propagates hypermethylation at T cell differentiation–regulating genes to promote leukemic transformation 2018 ·Journal of Clinical Investigation ·Changshan Wang, Motohiko Oshima, Daisuke Sato, Hirotaka Matsui, Sho Kubota, Kazumasa Aoyama, Yaeko Nakajima‐Takagi, Shuhei Koide, Jun Matsubayashi, Makiko Mochizuki‐Kashio, (unknown), Jie Bai, Toshitaka Nagao, Akinori Kanai, Atsushi Iwama, Goro Sashida	26
10	Dual Inhibition of EZH2 and EZH1 Sensitizes PRC2-Dependent Tumors to Proteasome Inhibition 2017 ·Clinical Cancer Research ·(unknown), Naoya Mimura, Motohiko Oshima, Atsunori Saraya, Shuhei Koide, Yuko Kato, Kazumasa Aoyama, Yaeko Nakajima‐Takagi, Changshan Wang, Tetsuhiro Chiba, Anqi Ma, Jian Jin, Tohru Iseki, Chiaki Nakaseko, Atsushi Iwama	60
11	Bmal1 regulates inflammatory responses in macrophages by modulating enhancer RNA transcription 2017 ·Scientific Reports ·Yumiko Oishi, Shinichiro Hayashi, Takayuki Isagawa, Motohiko Oshima, Atsushi Iwama, Shigeki Shimba, Hitoshi Okamura, Ichiro Manabe	69
12	A New Conditionally Immortalized Human Fetal Brain Pericyte Cell Line: Establishment and Functional Characterization as a Promising Tool for Human Brain Pericyte Studies 2017 ·Molecular Neurobiology ·(unknown), Yuchen Sun, (unknown), (unknown), Motoyuki Itoh, (unknown), Motohiko Oshima, Atsushi Iwama, Kosuke Saito, Naohiko Anzai, Kan Chiba, Hidetaka Akita, Tomomi Furihata	31
13	Ezh2 regulates the Lin28/let-7 pathway to restrict activation of fetal gene signature in adult hematopoietic stem cells 2016 ·Experimental Hematology ·Motohiko Oshima, (unknown), Makiko Mochizuki‐Kashio, Tomoya Muto, Satoru Miyagi, Shuhei Koide, (unknown), George Wendt, Atsunori Saraya, Changshan Wang, Kazuya Shimoda, Yutaka Suzuki, Atsushi Iwama	32
14	EZH2 loss in hematopoietic stem cells predisposes mice to develop heterogeneous malignancies in an EZH1-depenedent manner 2015 ·Experimental Hematology ·Makiko Mochizuki‐Kashio, Goro Sashida, Kazumasa Aoyama, Changshan Wang, T. Tomioka, Motohiko Oshima, Atsushi Iwama	1
15	Histone methyltransferase Setdb1 regulates energy metabolism in hematopoietic stem and progenitor cells 2015 ·Experimental Hematology ·Shuhei Koide, Keiyo Takubo, Motohiko Oshima, Satoru Miyagi, Atsunori Saraya, Changshan Wang, Hirotaka Matsui, Hiroshi Kimurâ, Yoichi Shinkai, Toshio Suda, Atsushi Iwama	3
16	Depletion of Sf3b1 impairs proliferative capacity of hematopoietic stem cells but is not sufficient to induce myelodysplasia 2014 ·Blood ·Changshan Wang, Goro Sashida, Atsunori Saraya, (unknown), Shuhei Koide, Motohiko Oshima, Kyoichi Isono, Haruhiko Koseki, Atsushi Iwama	35
17	Concurrent loss of Ezh2 and Tet2 cooperates in the pathogenesis of myelodysplastic disorders 2013 ·The Journal of Experimental Medicine ·Tomoya Muto, Goro Sashida, Motohiko Oshima, George Wendt, Makiko Mochizuki‐Kashio, Yasunobu Nagata, Masashi Sanada, Satoru Miyagi, Atsunori Saraya, Asuka Kamio, Genta Nagae, Chiaki Nakaseko, Koutaro Yokote, Kazuya Shimoda, Haruhiko Koseki, Yutaka Suzuki, Sumio Sugano, Hiroyuki Aburatani, Seishi Ogawa, Atsushi Iwama	137
18	Metformin, a Diabetes Drug, Eliminates Tumor-Initiating Hepatocellular Carcinoma Cells 2013 ·PLoS ONE ·Tomoko Saito, Tetsuhiro Chiba, (unknown), Yoh Zen, Motohiko Oshima, Shuhei Koide, Tenyu Motoyama, Sadahisa Ogasawara, Eiichiro Suzuki, Yoshihiko Ooka, Akinobu Tawada, Motohisa Tada, Fumihiko Kanai, Yuichi Takiguchi, Atsushi Iwama, Osamu Yokosuka	65
19	Genome-wide analysis of target genes regulated by HoxB4 in hematopoietic stem and progenitor cells developing from embryonic stem cells 2011 ·Blood ·Motohiko Oshima, Mitsuhiro Endoh, Takaho A. Endo, Tetsuro Toyoda, Yaeko Nakajima‐Takagi, Fumihiro Sugiyama, Haruhiko Koseki, Michael Kyba, Atsushi Iwama, Mitsujiro Osawa	38
20	Reduction of MPO-ANCA epitopes in SCG/Kj mice by 15-deoxyspergualin treatment restricted by IgG2b associated with crescentic glomerulonephritis 2010 ·Lara D. Veeken ·(unknown), Tomokazu Nagao, Ryusaku Kusunoki, (unknown), Motohiko Oshima, (unknown), Toshinori Nakayama, Masaru Tanokura, Kazuo Suzuki	9

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact